Action Potential Venture Capital

Action Potential Venture Capital is GlaxoSmithKline's (GSK) $50 million strategic venture capital fund created to invest in companies that are pioneering bioelectronic medicines and technologies . The fund will build a portfolio with five to seven companies over the next five years . The focus for investments will be in three main areas: new start-up companies that aim to pursue the vision of bioelectronic medicines; existing companies with technologies that are interacting with the peripheral nervous system through first-generation devices that can stimulate or block electrical impulses; and companies advancing technology platforms that will underpin these treatment modalities .